SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001008848-11-000037
Filing Date
2011-05-09
Accepted
2011-05-09 07:29:47
Documents
15
Period of Report
2011-03-31

Document Format Files

Seq Description Document Type Size
1 form10q1stqtr2011.htm 10-Q 448643
2 exhibit1014.htm EX-10.14 735508
3 exhibit1041.htm EX-10.41 320733
4 exhibit1059.htm EX-10.59 243322
5 exhibit1060.htm EX-10.60 26816
6 CEO CERTIFICATION exhibit311.htm EX-31.1 15045
7 CFO CERTIFICATION exhibit312.htm EX-31.2 15047
8 CERT OF CEO exhibit321.htm EX-32.1 6300
9 CERT OF CFO exhibit322.htm EX-32.2 6618
10 elanndatimeline2.jpg GRAPHIC 72885
  Complete submission text file 0001008848-11-000037.txt   3519089

Data Files

Seq Description Document Type Size
11 acor-20110331.xml EX-101.INS 242841
12 acor-20110331.xsd EX-101.SCH 13331
13 acor-20110331_cal.xml EX-101.CAL 44141
14 acor-20110331_lab.xml EX-101.LAB 169604
15 acor-20110331_pre.xml EX-101.PRE 87466
Mailing Address
Business Address 15 SKYLINE DRIVE HAWTHORNE NY 10532 914-347-4300
ACORDA THERAPEUTICS INC (Filer) CIK: 0001008848 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50513 | Film No.: 11821367
SIC: 2836 Biological Products, (No Diagnostic Substances)